Patents by Inventor Jerry A. Murry

Jerry A. Murry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Altenrative Forms Of The Phosphodeisterase -4 Inhibitor N-Cyclopropyl-1- -3{3-[(1-Oxidopyryidin-3-Yl) Phenyl]-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxyamide
    Publication number: 20080119509
    Abstract: The present invention is directed to alternative forms of the title phosphodiesterase 4 inhibitor which has the structural formula shown immediately below: Compound IX
    Type: Application
    Filed: April 22, 2005
    Publication date: May 22, 2008
    Inventors: Sophie-Dorothee Clas, Rafik Naccache, Hongshi Yu, Jerry Murry, Narayan Variankaval
  • Polymorphic Forms of a Gabaa Agonist
    Publication number: 20080085913
    Abstract: The present invention is directed to novel polymorphic forms of the compound 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrate (gaboxadol monohydrate). The invention is further concerned with pharmaceutical compositions containing the polymorphic forms as an active ingredient, methods for treatment of disorders susceptible to amelioration by GABAA receptor agonism with the polymorphic forms, and processes for the preparation of the polymorphic forms.
    Type: Application
    Filed: January 26, 2006
    Publication date: April 10, 2008
    Applicant: H. LUNDBECK A/S
    Inventors: Daniel Kumke, Jerry Murry, Bryon Simmons, Feng Xu
  • Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
    Publication number: 20080045725
    Abstract: The present invention is concerned with novel processes for the preparation of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof, and (?)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof. These compounds have pharmaceutical utility and are known to be useful for treating e.g., depression, anxiety disorders, eating disorders and urinary incontinence.
    Type: Application
    Filed: April 26, 2007
    Publication date: February 21, 2008
    Inventors: Jerry Murry, Edward Corley, Feng Xu, Bryon Simmons
  • Process and intermediates for the preparation of 4-aryl piperidines
    Patent number: 6998488
    Abstract: A novel process is provided for the preparation of 4-aryl piperidines, and the useful intermediates obtained therein. These compounds are intermediates for the synthesis of melanocortin-4 receptor (MC-4R), which are useful for the treatment of disorders such as obesity, diabetes, male sexual dysfunction, and female sexual dysfunction.
    Type: Grant
    Filed: March 8, 2004
    Date of Patent: February 14, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Genevieve N. Boice, Karen M. Conrad, Edward G. Corley, Louis Matty, Jr., Jerry A. Murry, Cecile G. Savarin
  • Method of preparing inhibitors phosphodiesterase-4
    Publication number: 20060019981
    Abstract: In one aspect, the present invention is directed to a one pot method of preparing intermediates of Formula (V), which are useful in making inhibitors of phosphodiesterase-4: The present invention is also directed to a method of preparing phosphodiesterase inhibitors comprising the Formula (IX, IXa)
    Type: Application
    Filed: November 18, 2003
    Publication date: January 26, 2006
    Inventors: Jennifer Albaneze-Walker, Jerry Murry, Arash Soheili, Shawn Springfield
  • Sorbitol dehydrogenase inhibitors
    Patent number: 6869943
    Abstract: This invention is directed to sorbitol dehydrogenase inhibitory compounds of the formula I, wherein R1, R2 and R3 are as defined in the specification. This invention is also directed to pharmaceutical compositions containing those compounds and methods of treating or preventing diabetic complications, particularly diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, diabetic macroangiopathy and diabetic cardiomyopathy by administering such compounds to a mammal suffering from diabetes and therefore at risk for developing such complications. This invention is also directed to pharmaceutical compositions comprising a combination of compound of formula I of this invention with an aldose reductase inhibitor and to methods of treating or preventing diabetic complications therewith.
    Type: Grant
    Filed: August 21, 2003
    Date of Patent: March 22, 2005
    Assignee: Pfizer Inc
    Inventors: Margaret Y. Chu-Moyer, Jerry A. Murry, Banavara L. Mylari, William J. Zembrowski
  • Process and intermediates for the preparation of 4-aryl piperidines
    Publication number: 20040181070
    Abstract: A novel process is provided for the preparation of 4-aryl piperidines, and the useful intermediates obtained therein. These compounds are intermediates for the synthesis of melanocortin-4 receptor (MC-4R), which are useful for the treatment of disorders such as obesity, diabetes, male sexual dysfunction, and female sexual dysfunction.
    Type: Application
    Filed: March 8, 2004
    Publication date: September 16, 2004
    Inventors: Genevieve N. Boice, Karen M. Conrad, Edward G. Corley, Louis Matty, Jerry A. Murry, Cecile G. Savarin
  • Process for the preparation of non-steroidal glucocorticoid receptor modulators
    Patent number: 6727392
    Abstract: A process for preparing a compound of the formula useful as a non-steroidal glucocorticoid receptor modulator.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: April 27, 2004
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Jerry A. Murry, Timothy D. White
  • Sorbitol dehydrogenase inhibitors
    Publication number: 20040077671
    Abstract: This invention is directed to sorbitol dehydrogenase inhibitory compounds of the formula I, 1
    Type: Application
    Filed: August 21, 2003
    Publication date: April 22, 2004
    Inventors: Margaret Y. Chu-Moyer, Jerry A. Murry, Banavara L. Mylari, William J. Zembrowski
  • Sorbitol dehydrogenase inhibitors
    Patent number: 6660740
    Abstract: This invention is directed to sorbitol dehydrogenase inhibitory compounds of the formula I, wherein R1, R2 and R3 are as defined in the specification. This invention is also directed to pharmaceutical compositions containing those compounds and methods of treating or preventing diabetic complications, particularly diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, diabetic macroangiopathy and diabetic cardiomyopathy by administering such compounds to a mammal suffering from diabetes and therefore at risk for developing such complications. This invention is also directed to pharmaceutical compositions comprising a combination of a compound of formula I of this invention with an aldose reductase inhibitor and to methods of treating or preventing diabetic complications therewith.
    Type: Grant
    Filed: March 10, 2003
    Date of Patent: December 9, 2003
    Assignee: Pfizer Inc
    Inventors: Margaret Y. Chu-Moyer, Jerry A. Murry, Banavara L. Mylari, William J. Zembrowski
  • Process for the preparation of non-steroidal glucocorticoid receptor modulators
    Publication number: 20030120081
    Abstract: A process for preparing a compound of the formula 1
    Type: Application
    Filed: October 15, 2002
    Publication date: June 26, 2003
    Inventors: Jerry A. Murry, Timothy D. White
  • Process for the preparation of non-steroidal glucocorticoid receptor modulators
    Patent number: 6570020
    Abstract: A process for preparing a compound of the formula useful as a non-steroidal glucocorticoid receptor modulator.
    Type: Grant
    Filed: October 22, 2001
    Date of Patent: May 27, 2003
    Assignee: Pfizer Inc.
    Inventors: Jerry A. Murry, Timothy D. White
  • Sorbitol dehydrogenase inhibitors
    Publication number: 20030065179
    Abstract: This invention is directed to sorbitol dehydrogenase inhibitory compounds of the formula I, 1
    Type: Application
    Filed: February 28, 2002
    Publication date: April 3, 2003
    Inventors: Margaret Y. Chu-Moyer, Jerry A Murry, Banavara L Mylari, William J Zembrowski
  • Synthesis of substituted imidazoles
    Publication number: 20030055255
    Abstract: The present invention prepares imidazoles by the selective closure of a keto-amide to form the imidazolyl ring. In particular, the present invention selectively closes a keto-amide substituted with three rings to form a tri-substituted imidazole.
    Type: Application
    Filed: June 20, 2002
    Publication date: March 20, 2003
    Inventors: Karen Marcantonio, Lisa Frey, Doug Frantz, Jerry A. Murry, Richard Tillyer
  • Process for the preparation of non-steroidal glucocorticoid receptor modulators
    Publication number: 20020087005
    Abstract: A process for preparing a compound of the formula 1
    Type: Application
    Filed: October 22, 2001
    Publication date: July 4, 2002
    Inventors: Jerry A. Murry, Timothy D. White